ARTICLE | Financial News
Audentes Therapeutics completes IPO
July 25, 2016 7:00 AM UTC
Audentes Therapeutics Inc. (NASDAQ:BOLD), San Francisco, Calif. Business: Gene/Cell therapy, Cardiovascular, Endocrine/Metabolic Date completed: 2016-07-19 Type: IPO Raised: $75 million Shares: 5 mill...